Chiesi Clinical Trial Site 840830 — Medford, Oregon

Chiesi Clinical Trial Site 840830 is a clinical research site located in Medford, Oregon, United States 97504.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Chiesi Clinical Trial Site 840830 has participated in 1 clinical trials.

Therapeutic areas: Asthma.

Sponsors: Chiesi Farmaceutici S.p.A..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Medford

Browse all research sites in Oregon · View every site in Medford

• GSK Investigational Site
• Research Site
• Velocity Clinical Research Medford
• Asante Rogue Regional Medical Center
• Novartis Investigative Site
• Clinical Research Institute of Southern Oregon PC
• Providence Medford Medical Center
• Sunstone Medical Research
• Pfizer Investigational Site
• Rogue Valley Medical Center
• Velocity Clinical Research
• Duramed Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chiesi Clinical Trial Site 840830?

Chiesi Clinical Trial Site 840830 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chiesi Clinical Trial Site 840830 conducted?

Chiesi Clinical Trial Site 840830 has 1 clinical trials on record. Their work covers Asthma.

Is Chiesi Clinical Trial Site 840830 accredited by Crixeo Clinical Trials?

Chiesi Clinical Trial Site 840830 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chiesi Clinical Trial Site 840830?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.